Serum metabolic profiling of abnormal savda by liquid chromatography/mass spectrometry

被引:55
作者
Yin, Peiyuan [2 ]
Mohemaiti, Patamu [1 ]
Chen, Jing [2 ]
Zhao, Xinjie [2 ]
Lu, Xin [2 ]
Yimiti, Adilijiang [1 ]
Upur, Halmurat [1 ]
Xu, Guowang [2 ]
机构
[1] Xinjiang Med Univ, Urumqi 830001, Peoples R China
[2] Chinese Acad Sci, Dalian Inst Chem Phys, Natl Chromatog R&A Ctr, Dalian 116023, Peoples R China
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2008年 / 871卷 / 02期
基金
中国国家自然科学基金;
关键词
metabonomics; metabolic profiling; abnormal savda; Uigur medicine;
D O I
10.1016/j.jchromb.2008.05.043
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Abnormal savda is a special symptom in Uigur medicine. The understanding of its metabolic origins is of great importance for the subsequent treatment. Here, a metabonomic Study of this symptom was carried Out using LC-MS based human serum metabolic profiling. Orthogonal signal correction partial least-squares discriminant analysis (OSC-PLS-DA) was used for the classification and prediction of abnormal savda. Potential biomarkers from metabonomics were also identified for a metabolic understanding of abnormal savda. As a result, our OSC-PLS-DA model had a satisfactory ability for separation and prediction of abnormal savda. The potential biomarkers including bilirubin, bile acids, tryptophan, phenylalanine and lyso-phosphatidylcholines indicated that abnormal savda could be related to some abnormal metabolisms within the body, including energy metabolism, absorption of nutrition, metabolism of lecithin on cell membrane, etc. To the best of our knowledge, this is the first study of abnormal savda based on serum metabolic profiling. The LC/MS-based metabonomic platform Could be a powerful tool for the classification of symptoms and for the development of this traditional medicine into an evidence-based one. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:322 / 327
页数:6
相关论文
共 26 条
[1]  
ABUDUREYIMU H, 2001, TRAD CHIN DRUG RES C, V12, P420
[2]  
Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802
[3]   Within-day reproducibility of an HPLC-MS-Based method for metabonomic analysis: Application to human urine [J].
Gika, Helen G. ;
Theodoridis, Georgios A. ;
Wingate, Julia E. ;
Wilson, Ian D. .
JOURNAL OF PROTEOME RESEARCH, 2007, 6 (08) :3291-3303
[4]   Chemometric models for toxicity classification based on NMR spectra of biofluids [J].
Holmes, E ;
Nicholls, AW ;
Lindon, JC ;
Connor, SC ;
Connelly, JC ;
Haselden, JN ;
Damment, SJP ;
Spraul, M ;
Neidig, P ;
Nicholson, JK .
CHEMICAL RESEARCH IN TOXICOLOGY, 2000, 13 (06) :471-478
[5]  
LI L, 2007, J EXP TRAD MED FORMU, V13, P45
[6]  
Lindon JC, 2000, CONCEPT MAGNETIC RES, V12, P289, DOI 10.1002/1099-0534(2000)12:5<289::AID-CMR3>3.0.CO
[7]  
2-W
[8]   A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model [J].
Martin, Francois-Pierre J. ;
Dumas, Marc-Emmanuel ;
Wang, Yulan ;
Legido-Quigley, Cristina ;
Yap, Ivan K. S. ;
Tang, Huiru ;
Zirah, Severine ;
Murphy, Gerard M. ;
Cloarec, Olivier ;
Lindon, John C. ;
Sprenger, Norbert ;
Fay, Laurent B. ;
Kochhar, Sunil ;
van Bladeren, Peter ;
Holmes, Elaine ;
Nicholson, Jeremy K. .
MOLECULAR SYSTEMS BIOLOGY, 2007, 3 (1)
[9]  
Nicholas D, 2004, URBAN MORPHOL, V8, P59
[10]  
Nicholson J, 2005, DRUG METAB REV, V37, P10